US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
CL

CLPT

Stock ClearPoint Neuro Inc
$13.72

Nasdaq Capital Market · Healthcare · US

Sharia status
COMPLIANT
Per our secondary compliance provider · assessed 2026-08-06
HTR non-permissible income 3.28%

Methodology breakdown computing — it will appear here on its own.

🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
🟠 NOT YET
The main driver: lagging the market by 11.1%. More negatives than positives right now. The setup isn't ready — check...
53
of 100
Setup confidence — system conviction, not win probabilityC
Trade plan MOM · SCALP
Entry
$16.67
Stop
$16.50
Target
$17.01
Risk : Reward 2.0R
Why this signal?
Structure0 of 5 timeframes bullish · 100.0% aligned
VWAPPrice below VWAP ($13.73)
VolumeRelative volume 5.2× the 20-day average
Momentum10-day rate of change -15.6%
Overall readNOT YET

ClearPoint Neuro Inc (CLPT) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-06). See the full ratio breakdown and business-activity screen below for the reasoning.

Market & analysts
Price target
$23.50
+71.3% · 2 analysts
Institutional own.
52.4%
of shares
Momentum (10d)
-15.6%
rate of change
SMC grade
C · 53
100.0% aligned
COMPLIANT
Sharia compliance
3.28%
Non-permissible income — HTR, from filings (2025-12-31)
C · 53
SMC grade — 100.0% timeframe alignment
-15.6%
Rate of change (10d)
$23.50
Price target (+71.3%) · 2 analysts
52.4%
Institutional ownership

🕌 In-house Compliance Research

Computing the full ratio and business-activity breakdown for CLPT — this runs off the critical path so the page paints first. It will appear here on its own.

29.6024.3719.1313.898.662025-09-122026-03-132026-09-11

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
12.82
S2
13.07
S1
13.27
PIVOT
13.52
R1
13.72
R2
13.97
R3
14.17

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
11.63 16.29
±16.72% from 13.96, made 2026-09-07 · resolves 2026-09-14
STRONG SELL
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 22437 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

STRONG SELL
19 indicators
OscillatorsNEUTRAL
3 buy · 1 neutral · 3 sell
Moving averagesSTRONG SELL
1 buy · 0 neutral · 11 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)40.20NEUTRAL
Stochastic %K (14)10.49BUY
CCI (20)-125.59BUY
Williams %R (14)-89.51BUY
MACD (12,26,9)-0.20SELL
ROC (10)-13.93SELL
Momentum (10)-2.22SELL
EMA (10)14.24SELL
SMA (10)14.30SELL
EMA (20)14.62SELL
SMA (20)15.00SELL
EMA (30)14.78SELL
SMA (30)14.80SELL
EMA (50)14.81SELL
SMA (50)15.22SELL
EMA (100)14.52SELL
SMA (100)14.26SELL
EMA (200)14.85SELL
SMA (200)13.42BUY

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About ClearPoint Neuro Inc

Healthcare · Medical Devices

ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

clearpointneuro.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Latest Signal — 2026-08-25

MOM
Type · SCALP
16.67
Entry
16.50
Stop
17.01
Target
LOSS
Outcome
Verdict

🟠 NOT YET

The main driver: lagging the market by 11.1%. More negatives than positives right now. The setup isn't ready — check back when the trend or RSI changes.

Scores: 1 bullish / 2 bearish

Grade verdict

Average — needs more confirmation before sizing up

SMC — Top Down

TimeframeBiasBars
📅 Daily BEARISH 62
⏰ 4H BEARISH 36
🕐 1H BEARISH 98
⏱ 15-Min BEARISH 130
⏲ 5-Min BEARISH 234

Momentum & Volume

-0.46
MACD (no fresh cross)

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-08 · Asset managers net 912361 (-21819)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.